Dipesh Chodvadia, Author at Lambda CRO

Insights – Administering Iron Sucrose IV Injection through Infusion Pump to over 150 Healthy Participants

Post author:Dipesh Chodvadia
Post published:November 30, 2023
Post category:Case-Study

CASE-STUDY

Case-study: Clinical Safety & Pharmacovigilance - Meeting MI & PV Obligations for a COVID-19 Vaccine

Meeting MI PV Obligations for a COVID-19 Vaccine Partnering for Multi-Country Compliance

Post author:Dipesh Chodvadia
Post published:November 30, 2023
Post category:Case-Study

CASE-STUDY

Advancing Breast Cancer Research: Lambda & Novum's Commitment to Patient-Centric Trials

Advancing Breast Cancer Research – Lambda and Novum’s Commitment to Patient-Centric Trials

Post author:Dipesh Chodvadia
Post published:November 30, 2023
Post category:Case-Study

CASE-STUDY

CASE-STUDY: Advancing Pediatric Clinical Trials Overcoming Challenges in the Clinical Trial of Pegfilgrastim for Rhabdomyosarcoma & Wilms' Tumor

Advancing Pediatric Clinical Trials – Overcoming Challenges in the Clinical Trial of Pegfilgrastim

Post author:Dipesh Chodvadia
Post published:November 30, 2023
Post category:Case-Study

CASE-STUDY

Addressing Clinical Trials Challenges & Complexity with our EDC system: BizNET

Post author:Dipesh Chodvadia
Post published:November 30, 2023
Post category:Late Phase Services & Capabilities

CASE-STUDY

Accelerating Patient Recruitment: Atopic Dermatitis Trials | Topical Tacrolimus

Post author:Dipesh Chodvadia
Post published:November 30, 2023
Post category:Case-Study

CASE-STUDY

Lambda Therapeutic Research reaffirms its status as a leading global CRO by clinching two prestigious awards. The company secured the 'Regulatory Excellence' Award at the CPHI Awards 2023 and the 'Industry Partner of the Year' Award at the Global Generics & Biosimilar Awards 2023.